期刊文献+

高致病性人禽流感 H5N1病毒 HA 与 M1蛋白共表达制备新型病毒样颗粒 被引量:1

Characterizaiton of virus-like particles prepared by Bac-to-Bac system co-expressing HA and M1 ;protein of highly pathogenic avian influenza H5N1
原文传递
导出
摘要 目的:制备由H5N1亚型人禽流感病毒血凝素(HA)和基质蛋白1(M1)两种结构蛋白组装而成的H5亚型流感病毒样颗粒( viruslike particles,VLPs)并检测其生物活性。方法构建同时包含 A/Indonesia/05/2005( H5N1) HA 和 A/Anhui/01/2005( H5N1) M1基因的重组转移载体pFBD-M1-HA,筛选获得重组杆粒(重组杆状病毒质粒) rBacmid-M1-HA后,转染Spodoptra frugiperda (Sf9)昆虫细胞,包装重组杆状病毒rBV-M1-HA;Western blot和间接免疫荧光鉴定HA和M1的表达;大量制备并纯化后,在透射电镜下观察VLPs的形态结构;血凝试验检测VLPs的生物活性。结果应用昆虫细胞-杆状病毒表达系统表达H5N1 HA和M1两种结构蛋白可以高效组装产生流感VLPs,纯化后的VLPs血凝效价为1024 HAU/50μl。结论成功利用A/Indonesia/05/2005(H5N1)来源HA和A/Anhui/01/2005(H5N1)来源M1两种结构蛋白,在杆状病毒表达系统中制备有较好生物活性的人禽流感病毒H5亚型VLPs,为下一步研究人H5亚型禽流感VLPs疫苗奠定基础。 Objective To express and characterize the virus-like particles( VLPs) of H5 subtype containing of hemagglutinin ( HA ) and matrix 1 ( M1 ) protein by using Baculovirus-insect cells .Methods Full length genes encoding HA protein from the A/Indonesia/05/2005(H5N1) strain and the M1 protein from the A/Anhui/01/2005 ( H5N1 ) strain were cloned into a baculovirus expression vector to construct pFBD-M1-HA.The expression of HA and M1 proteins were detected by Western blot and indirect immunoflu-orescence after the transfection of Spodoptra frugiperda (Sf9) insect cells with recombinant baculovirus.Pu-rified VLPs were analyzed by SDS-PAGE and visualized with transmission electron microscope.The biologi-cal activity of purified VLPs was detected by hemagglutination test.Results The HA and M1 proteins of H5 subtype expressed by baculovirus-insect cells could be self-assembled into the functional mature VLPs.The hemagglutination titer of VLPs was as high as 1024 HAU/50μl.Conclusion The H5 subtype VLPs as pre-pared in this study would pave a way for the development of a candidate recombinant A ( H5) vaccine.
出处 《中华微生物学和免疫学杂志》 CAS CSCD 北大核心 2015年第4期286-291,共6页 Chinese Journal of Microbiology and Immunology
基金 传染病防治重大专项(2013 ZX10004001-004) 国家自然科学基金(81302607)
关键词 禽流感病毒 H5N1 病毒样颗粒 杆状病毒表达系统 Influenza virus H5N1 Virus like particles (VLPs) Baculovirus expression system
  • 相关文献

参考文献22

  • 1Cheung CL, Rayner JM, Smith GJ, et al. Distribution of amanta- dine-resistant H5NI avian influenza variants in Asia[ J]. J Infect Dis, 2006, 193(12) : 1626-1629.
  • 2de long MD, Tran TT, Truong HK, et al. Oseltamivir resistance during treatment of influenza A ( H5N1 ) infectinn[J]. N Engl J Med, 2005, 353(25): 2667-2672.
  • 3Hurt AC, Se|leek P, Komadina N, et al. Susceptibility of highly pathogenic A (H5N1) avian influenza viruses to the neuramini- dase inhibitors and adamantanes[J]. Ant|viral Res, 2007, 73 (3) : 228-231.
  • 4Le QM, Kiso M, Someya K, et al. Avian flu: isolation of drug- resistant H5N1 virus[J]. Nature, 2005, 437(7062) : 1108.
  • 5Wu WL, Chen Y, Wang P, et al. Antigenic Profile of avian H5N1 viruses in Asia from 2002-2007 [ J]. J Virol, 2008, 84 (4) : 1798-1807.
  • 6Linster M, van Boheemen S, de Graaf M,et al. Identification, characterization, and natural selection of mutations driving air- borne transmission of A/H5N1 virus [ J ]. Cell, 2014,157 ( 2 ) : 329-339.
  • 7施金荣,杨晓明,杜慧,邱阿明,王妮丹,黄晓媛.H5N1亚型禽流感病毒样颗粒的构建及鉴定[J].中国生物制品学杂志,2013,26(2):145-148. 被引量:2
  • 8Bright RA , Carter DM, Crevar C J, et al. Cross-clade protective immune responses to influenza viruses with I-ISN1 HA and NA elicited by an influenza virus-like particle[ J]. PLoS One, 2008, 1(1): el501.
  • 9Quan FS, Huang C, Compans RW, et al. Virus-like particle vac- cine induces protective immunity against homologous and heterolo- gous strains of influenza virus[J]. J Virol, 2007, 81 (7) : 3514- 3524.
  • 10Smith GE, Flyer DC, Raghunandan R, et al. Development of in- fluenza HTN9 virus like particle (VLP) vaccine: homologous A/ Anhui/1/2013 ( H7N9 ) protection and heterologous A/chicken/ Jaliscn/CPA1/2012 (H7N3) cross-protection in vaccinated mice challenged with H7N9 virus [ J ]. Vaccine, 2013, 31 (40) : 4305 -4313.

二级参考文献115

  • 1管洁,周育森.禽流感病毒M2蛋白研究进展[J].微生物学免疫学进展,2007,35(2):84-86. 被引量:4
  • 2朱智勇,丁晓航,朱函坪,李岩金,陈学奎,沈吉友,张涛,何培江,姚苹苹,徐芳,翁景清,谢荣辉,赵芝雅,龚华岳,郭志宏,苏波,孙淑滨,梁伟峰.人用H5N1禽流感裂解疫苗的制备工艺[J].中国生物制品学杂志,2007,20(7):503-506. 被引量:3
  • 3郇丽芳,姚立红,陈爱珺,程从升,贾润清,田青,薄洪,郭建强,王敏,舒跃龙,张智清.人H5N1流感病毒血凝素蛋白DNA疫苗的构建及其免疫原性研究[J].病毒学报,2007,23(5):366-370. 被引量:3
  • 4Song JM, Hossain J, Yoo DG, et al. Protective immunity against HSNI influenza virus by a single dose vaccination with virus- like particles [J]. Virology, 2010, 405 ( 1 ): 165-175.
  • 5Bender C, Hall H, Huang J, et ol. Characterization of the surface proteins of influenza A (H5N1) viruses isolated from humans in 1997-1998 [J]. Virology, 1999, 254 ( 1 ): 115-123.
  • 6Horimoto T, Kawaoka Y. Strategies for developing vaccine against H5N1 influenza A viruses [J]. Trends Mol Med, 2006, 12 (11): 506-514.
  • 7Chang RL, Lai SY, Chang PC, et al. Production of immunogenic one-component avian H7-subtype influenza virus-like particles [J]. Proc Biochem, 2011, 46 (6): 1292-1298.
  • 8Latham T, Galarza JM. Formation of wild-type and chimeric influenza virus-like particles following simultaneous expression of only four structural proteins [J]. J Virol, 2001, 75 (13): 6154-6165.
  • 9Pushko P, Tumpey TM, Van Hoeven N, et al. Evaluation of influenza virus-like particles and Novasome adjuvant as candidate vaccine for avain influenza [J]. Vaccine, 2007, 25 (21) : 4283-4290.
  • 10Bright RA, Carter DM, Daniluk S, et al. Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglution [J]. Vaccine, 2007, 25 (19) : 3871-3878.

共引文献13

同被引文献17

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部